Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Tomotherapy Stories

2014-04-03 08:30:40

Acceptance of Accuray technologies in key markets adds to company's global market share SUNNYVALE, Calif., April 3, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today continued momentum in adoption of its CyberKnife® and TomoTherapy® Systems in Europe, India, the Middle East and Africa (EIMEA). Accuray has expanded its installed base in the EIMEA region; Accuray radiation therapy systems have been used to treat more than 45,000 patients in EIMEA, further positioning...

2014-02-11 08:32:51

SUNNYVALE, Calif., Feb. 11, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that overall user satisfaction for its TomoTherapy(®) System has increased for the fifth consecutive quarter, according to the Q4 2013 MD Buyline Market Intelligence Briefing(TM). In addition, the latest report illustrates Accuray has exceeded market average for user satisfaction among linear accelerator vendors for the second consecutive quarter. MD Buyline, an independent market...

2013-11-25 08:27:50

More than 700 CyberKnife® and TomoTherapy® Systems Have Treated More Than Half a Million Patients Worldwide SUNNYVALE, Calif., Nov. 25, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today continued momentum in global adoption of its CyberKnife® and TomoTherapy® Systems. Accuray has expanded its installed base to more than 700 systems worldwide which have been used to treat more than half a million patients, further positioning the company as a leader in...

2013-10-09 08:24:12

NEW YORK, October 9, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports highlighting Amarin Corporation plc (NASDAQ: AMRN), Discovery Laboratories Inc. (NASDAQ: DSCO), Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL), Novavax, Inc. (NASDAQ: NVAX), and Accuray Incorporated (NASDAQ: ARAY). Today's readers may access these reports free of charge - including full price...

2013-10-03 08:30:13

Data Supports Growing Use of CyberKnife® SBRT for Prostate Cancer SUNNYVALE, Calif., Oct. 3, 2013 /PRNewswire/ -- ASTRO 2013 (Atlanta) - Accuray Incorporated (Nasdaq: ARAY) announced today that studies presented at the 55th Annual American Society for Radiation Oncology (ASTRO) Meeting in Atlanta, September 22 - 25, 2013 continue to reinforce evidence of clinical and quality of life benefits for the CyberKnife® and TomoTherapy® Systems. A variety of indications including prostate,...

2013-09-22 08:20:18

World's Largest Annual Gathering of the Radiation Oncology Community Provides Multiple Opportunities to Learn about the CyberKnife® M6(TM) Series and the TomoTherapy® H(TM) Series Systems SUNNYVALE, Calif. and ATLANTA, Sept. 22, 2013 /PRNewswire/ -- ASTRO 2013 -- Accuray Incorporated (Nasdaq: ARAY) announced today its momentum in gaining adoption for both the new CyberKnife® M6(TM) Series and TomoTherapy® H(TM) Series Systems at the 55th Annual American Society for Radiation...

2013-09-03 08:28:51

Accuray Appoints Successor SUNNYVALE, Calif., Sept. 3, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that Derek Bertocci has resigned as Senior Vice President and Chief Financial Officer of the company effective September 2, 2013. Today, Accuray has appointed Gregory Lichtwardt, executive vice president, chief financial officer, effective immediately. Mr. Bertocci is anticipated to continue in a consulting role with the Company. Mr. Lichtwardt, age 59,...

2013-08-27 16:24:42

Continued Momentum in New Order Activity and Backlog Provides Guidance for Fiscal 2014 SUNNYVALE, Calif., Aug. 27, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today financial results for the fourth quarter and fiscal year ended June 30, 2013. Non-GAAP results are provided to enhance understanding of Accuray's ongoing core results of operations. Accuray announced continued strength in new orders booked in the fourth quarter and first patients treated in the...

2013-08-16 08:24:01

SUNNYVALE, Calif., Aug. 16, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today its participation in the 22(nd) China International Medical Instruments and Equipment Exhibition and Seminar (CHINA-HOSPEQ), taking place from Friday, August 16 to Sunday, August 18, 2013. For the first time, China's hospital procurement officials will be able to see firsthand Accuray's CyberKnife and TomoTherapy Systems at CHINA-HOSPEQ 2013 (booth #G02). On display in the booth...

2013-07-16 23:27:38

The U.S. radiation therapy market appears to be rebounding after a major decline in 2009, with radiation oncology centers budgeting more money for capital equipment purchases this year compared to four years ago, according to a new study published by IMV Medical Information Division. Des Plaines, IL (PRWEB) July 16, 2013 The U.S. radiation therapy market appears to be rebounding after a major decline in 2009, with radiation oncology centers budgeting more money for capital equipment...